AMN Healthcare Services (AMN) Shares Skyrocket, What You Need To Know
AMN Healthcare Services (AMN) shares jumped significantly after reporting fourth-quarter sales that exceeded analyst estimates and providing a strong revenue forecast for the upcoming quarter. Despite an earnings miss, investors focused on the positive outlook. The company's stock has seen volatility but is up 17% year-to-date, though still below its 52-week high.
AMN Healthcare (AMN) Stock Rises After Exceeding Q4 Revenue, Upbeat 2026 Outlook - News and Statistics
AMN Healthcare (AMN) shares increased by 2.4% on February 20, 2026, after the company reported Q4 2025 revenue exceeding analyst expectations and provided a strong Q1 2026 revenue forecast of approximately $1.23 billion. Although adjusted earnings per share missed estimates, the upbeat revenue projection drove investor confidence. The stock, despite recent gains, remains significantly below its 52-week high from February 2025.
AMN Q4 Earnings Meet Estimates, Revenues Beat, Gross Margin Contracts
AMN Healthcare Services, Inc. (AMN) reported Q4 2025 adjusted EPS of 22 cents, meeting analyst estimates, while revenues of $748.2 million surpassed expectations. Despite the revenue beat, the company experienced a significant year-over-year decline in EPS and a contraction in gross margin. AMN provided Q1 2026 revenue guidance of $1.225-$1.240 billion, driven largely by labor disruption revenues, and projects long-term organic revenue growth of 4-6% annually.
AMN Healthcare Services (NYSE:AMN) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 10.8%
AMN Healthcare Services (NYSE:AMN) reported Q4 CY2025 results with revenue exceeding market expectations, growing 1.8% year-on-year to $748.2 million, and surprisingly strong Q1 CY2026 revenue guidance. Although adjusted EPS missed estimates, the company's operating margin improved, and the stock jumped 10.8% immediately after the report. Despite some positive quarterly developments, the company faces long-term challenges with declining EPS and projected revenue declines.
AMN HEALTHCARE SERVICES INC SEC 10-K Report
AMN Healthcare Services Inc. released its annual 10-K report for fiscal year 2025, reporting revenue of $2,730.4 million and a net loss of $95.7 million. The company is focusing on technological integration through its WorkWise and ShiftWise Flex platforms while navigating challenges including clinician burnout and client consolidation.
AMN Healthcare: Q4 Earnings Snapshot
AMN Healthcare Services reported a fourth-quarter loss of $7.7 million, with adjusted earnings of 22 cents per share meeting Wall Street expectations. The healthcare staffing company's revenue of $748.2 million exceeded analyst forecasts, while full-year losses narrowed to $95.7 million.
AMN Healthcare Services, Inc. Reports Q4 2025 Revenue of $748 Million with GAAP Loss of $0.20 per Share and Adjusted EPS of $0.22
AMN Healthcare reported Q4 2025 revenue of $748 million, a 2% year-over-year increase, alongside a GAAP net loss of $7.7 million and adjusted EPS of $0.22. While full-year 2025 revenue declined 8% to $2.73 billion, the company saw growth in travel nurse volume and significant debt reduction of $285 million for the year.
AMN Healthcare Services (NYSE:AMN) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 10.8%
AMN Healthcare Services (NYSE:AMN) reported Q4 CY2025 results that surpassed revenue expectations, with sales up 1.8% year-on-year to $748.2 million, and provided surprisingly strong Q1 CY2026 revenue guidance. Despite a miss on non-GAAP profit, the stock surged 10.8% following the announcement. The company's operating margin saw a significant increase, although long-term EPS has declined due to rising costs.
AMN Healthcare Services (NYSE:AMN) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 10.8%
AMN Healthcare Services reported Q4 CY2025 revenue of $748.2 million, beating analyst estimates and growing 1.8% year-over-year. Despite an EPS miss of $0.22 against the $0.27 consensus, the stock surged 10.8% due to exceptionally strong Q1 CY2026 revenue guidance of $1.23 billion, which nearly doubled analyst expectations.
72,603 Shares in AMN Healthcare Services Inc $AMN Bought by First National Bank of Omaha
First National Bank of Omaha acquired a new stake of 72,603 shares in AMN Healthcare Services Inc. (NYSE:AMN) valued at approximately $1.41 million during the third quarter. This purchase represents about 0.19% of the company's stock, contributing to the 99.23% institutional ownership. Several other hedge funds also adjusted their positions in AMN Healthcare, while Wall Street analysts currently hold a "Hold" consensus rating with an average price target of $22.42 for the stock.
AMN Healthcare Services, Inc. (AMN) Tops Q4 2025 Earnings Estimates — EPS $0.39 vs $0.20 Expected
AMN Healthcare Services, Inc. (AMN) reported Q4 2025 earnings per share of $0.39, significantly surpassing the consensus estimate of $0.20 by 95.2%. The company also recorded $2.7 billion in revenue for the quarter. Following the announcement, AMN shares saw a 1.4% increase in after-hours trading, reaching $16.68.
AMN Healthcare Crushes Q4 Earnings With 95.2% EPS Beat Despite Staffing Headwinds
AMN Healthcare reported Q4 2025 EPS of $0.39, significantly exceeding the Street's $0.20 estimate by 95.2%, marking the largest beat in the company's recent history despite a 7.7% decline in full-year revenue to $2.72B. The strong bottom-line performance comes amidst ongoing challenges in the healthcare staffing sector, with management indicating signs of stabilization ahead. While shares saw a modest increase, analysts remain cautious with a "hold" rating, but expect sequential improvement in 2026.
What To Expect From AMN Healthcare Services's (AMN) Q4 Earnings
AMN Healthcare Services (AMN) is set to announce its Q4 earnings, with analysts expecting a 1.5% year-on-year revenue decline to $723.9 million and adjusted earnings of $0.27 per share. The company has historically surpassed revenue estimates, and its peers like The Ensign Group and DaVita have reported mixed Q4 results. Despite a generally underperforming healthcare providers and services segment, AMN Healthcare is heading into earnings with an average analyst price target significantly above its current share price.
AMN Healthcare Services Inc (NYSE:AMN) Sees Large Decline in Short Interest
Short interest in AMN Healthcare Services (NYSE:AMN) decreased significantly by 18.6% in January, totaling 1,945,851 shares, which represents about 5.1% of the company's outstanding shares. The stock has a "Hold" consensus rating from analysts, with an average price target of $22.36, and traded at $16.23 with a negative P/E of -2.26. Institutional investors hold approximately 99.23% of the stock, with various hedge funds adjusting their positions during recent quarters.
AMN Healthcare Services Inc (NYSE:AMN) Receives Consensus Rating of "Hold" from Brokerages
AMN Healthcare Services Inc (NYSE:AMN) has received a consensus "Hold" rating from nine brokerages, with an average 12-month price target of $22.36. The stock opened at $16.23, trading near its one-year low, and institutional investors collectively own 99.23% of the shares. Several firms, including JPMorgan and BMO Capital Markets, recently raised their price targets for AMN.
AMN Healthcare Services Inc (AMN) Stock Analysis: Unveiling A 28% Potential Upside
AMN Healthcare Services Inc (AMN) is a major player in healthcare staffing and workforce solutions, currently trading near the lower end of its 52-week range. Despite recent performance challenges like declining revenue and negative EPS, analysts see a potential upside of 28.27% with an average target price of $20.86. The company maintains a healthy free cash flow and a strategic position in the evolving healthcare sector, though investor sentiment is mixed.
AMN Healthcare Services (AMN) Expected to Announce Earnings on Thursday
AMN Healthcare Services (NYSE:AMN) is scheduled to announce its Q4 2025 earnings after the market closes on Thursday, February 19th, 2026. Analysts project earnings per share of $0.22 and revenue of $723.1 million. The stock currently holds a "Hold" consensus rating from Wall Street with an average price target of $22.36, and institutional ownership is high at 99.23%.
Understanding the Setup: (AMN) and Scalable Risk
This article provides an analysis of Amn Healthcare Services Inc (NYSE: AMN), highlighting a near-term weak sentiment that could challenge mid-term strength within a broader long-term weak bias. It identifies resistance testing and suggests potential downside, outlining three distinct AI-generated trading strategies for different risk profiles. The strategies include position trading, momentum breakout, and risk hedging, along with a multi-timeframe signal analysis.
AMN Healthcare Services Announces Board Changes
AMN Healthcare Services, Inc. announced board changes, with R. Jeffrey Harris retiring from the Board of Directors at the 2026 Annual Meeting. Eric Palmer has been nominated to stand for election to the Board, bringing over 25 years of experience in the healthcare and insurance industries. These changes are effective at the 2026 Annual Meeting and are not due to any disagreements.
Allianz Asset Management GmbH Buys 196,466 Shares of AMN Healthcare Services Inc $AMN
Allianz Asset Management GmbH significantly increased its stake in AMN Healthcare Services Inc. by purchasing 196,466 additional shares, bringing its total to 773,246 shares valued at approximately $14.97 million. This move reflects a broader trend of increased institutional ownership, with AMN Healthcare Services now having 99.23% institutional ownership. Despite mixed analyst ratings, the company recently surpassed quarterly EPS and revenue estimates, although revenue was down year-over-year.
AMN Healthcare Services Announces Board Transition, Nominates New Director
AMN Healthcare Services announced that director R. Jeffrey Harris will retire from its Board in 2026 and will not seek re-election. In connection with this, the Board plans to nominate Eric Palmer, a veteran healthcare executive, to deepen its expertise in large-scale healthcare operations and strategic transformation. Analysts currently rate AMN stock as a Hold with a $21.50 price target, and TipRanks' AI Analyst, Spark, also rates it Neutral due to weak financial performance despite strong technicals.
AMN Healthcare Services director R. Jeffrey Harris to retire; board to nominate Eric Palmer
AMN Healthcare Services announced the retirement of director R. Jeffrey Harris, effective at the 2026 annual meeting of shareholders. The company's board plans to nominate Eric Palmer, who has over 25 years of healthcare leadership experience, as his replacement. This news follows AMN Healthcare's strong Q3 2025 financial results and recent analyst rating adjustments.
AMN Healthcare Services Announces Board Transition, Nominates New Director
AMN Healthcare Services announced that director R. Jeffrey Harris will retire at the 2026 annual meeting, with the company noting no disagreement led to his decision. In anticipation of this transition, the Board plans to nominate Eric Palmer, a veteran healthcare executive, to deepen the Board's expertise in large-scale healthcare operations and strategic transformation. Despite this governance change, Spark, TipRanks’ AI Analyst, rates AMN as Neutral due to weak financial performance, though technicals show strong momentum.
10 Health Care Stocks With Whale Alerts In Today's Session
This article identifies 10 healthcare stocks that are showing "whale alerts," indicating significant options trading activity by large investors. These alerts are used by traders to spot potential opportunities when option market estimations deviate from normal valuations, driven by high trading volumes. The report details specific put and call option activity for companies like CVS, Novo Nordisk, Cigna, Merck, and UnitedHealth Group, including strike prices, expiration dates, sentiment (bullish/bearish), and contract volumes.
Zacks Research Has Negative Outlook for AMN FY2026 Earnings
Zacks Research has lowered its FY2026 EPS estimate for AMN Healthcare Services (NYSE:AMN) to $0.68 from $0.69, while maintaining a "Hold" rating. This updated estimate is significantly lower than the consensus full-year EPS of $1.33. Despite beating last quarter's earnings and revenue estimates, the company's revenue saw a 7.7% year-over-year decline, contributing to a mixed analyst outlook and an average "Hold" rating with a $22.36 price target.
Zacks Research Has Negative Outlook of AMN Q2 Earnings
Zacks Research has lowered its Q2 2026 earnings per share estimate for AMN Healthcare Services (NYSE: AMN) to $0.08, down from $0.09, while maintaining a "Hold" rating on the stock. The firm also provided updated earnings estimates for Q3 2026 and Q3 2027. This negative outlook comes despite AMN Healthcare recently surpassing quarterly earnings estimates and revenue expectations, though its revenue was down year-over-year.
The Technical Signals Behind (AMN) That Institutions Follow
This article analyzes the technical signals for Amn Healthcare Services Inc (NYSE: AMN), indicating strong near and mid-term sentiment but a weak long-term outlook with elevated downside risk. It details AI-generated institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance levels.
AMN: Management Expects A Recovery, The Stock Is Still Cheap (NYSE:AMN)
AMN Healthcare Services is rated as a Strong Buy due to management's signal that the contingent labor market correction is nearing its end. The stock is currently trading at a significant discount, with management projecting margin expansion in 2026 and revenue growth of 6% from 2027 onwards. Despite risks such as a slow market recovery and execution on acquisitions, the current valuation suggests a potential for over $4 per share in earnings in the coming years.
AMN Healthcare Services, Inc.'s (NYSE:AMN) Price Is Right But Growth Is Lacking After Shares Rocket 28%
AMN Healthcare Services (NYSE:AMN) shares have recently surged by 28%, yet the company's price-to-sales (P/S) ratio remains low at 0.3x, hinting at underlying growth concerns. The company has experienced an 11% revenue decrease over the last year and a 50% drop over three years, with analysts forecasting a further 4.6% decline. This lack of growth relative to the industry suggests that the low P/S ratio is justified, and a sustained improvement in revenue performance is needed for the stock price to rise further.
AMN Healthcare Services, Inc.'s (NYSE:AMN) Share Price Boosted 28% But Its Business Prospects Need A Lift Too
AMN Healthcare Services, Inc. (NYSE:AMN) has seen a 28% rebound in its share price over the past month, yet it remains down 26% over the last year. Despite a low price-to-sales (P/S) ratio of 0.3x compared to an industry average of 1.3x, the company faces declining revenue, which decreased by 11% in the last year and 50% over three years. Analysts forecast a further 4.6% revenue decrease, contrasting with the industry's projected 6.4% growth, suggesting that the current low P/S ratio reflects underlying concerns about its business prospects.
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call for Thursday, February 19, 2026, at 5:00 p.m. Eastern Time to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook. The company will also issue an earnings news release after market close at approximately 4:15 p.m. ET on the same day. Interested parties can access a live webcast or register to participate via telephone; a replay will be available on the company's investor relations website.
AMN Healthcare Schedules Conference Call for Q4 2025 Financial Results and Q1 2026 Outlook
AMN Healthcare will host a conference call on February 19, 2026, at 5:00 p.m. Eastern Time to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook. The company expects to issue an earnings news release around 4:15 p.m. ET on the same day. Interested parties can access a live webcast via AMN Healthcare’s investor relations website or register to participate by phone.
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call for Thursday, February 19, 2026, at 5:00 p.m. Eastern Time, to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook. The company expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time on the same day. A live webcast and replay will be available on AMN Healthcare’s investor relations website.
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
AMN Healthcare Services, Inc. (NYSE: AMN) has scheduled a conference call for Thursday, February 19, 2026, at 5:00 p.m. Eastern Time, to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook. The company expects to release its earnings news after market close at approximately 4:15 p.m. ET on the same day. A live webcast and replay will be available through the company's investor relations website.
Precision Trading with Amn Healthcare Services Inc (AMN) Risk Zones
This article provides a precision trading analysis for Amn Healthcare Services Inc (AMN), highlighting strong near and mid-term sentiment but a weak long-term outlook. It identifies resistance testing, an exceptional 57.0:1 risk-reward short setup, and outlines three distinct AI-generated trading strategies tailored to different risk profiles and holding periods, including position, momentum breakout, and risk hedging strategies. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
AMN Healthcare Services Inc (NYSE:AMN) Receives Average Rating of "Hold" from Analysts
AMN Healthcare Services Inc (NYSE:AMN) has received a consensus "Hold" rating from nine analysts, with an average 12-month price target of $22.36. The company recently reported mixed quarterly results, beating EPS and revenue estimates but experiencing a 7.7% year-over-year revenue decline and a negative net margin. Institutional investors hold approximately 99% of the stock.
Equities Analysts Offer Predictions for AMN FY2026 Earnings
MarketBeat reports that equities analysts have revised their earnings predictions for AMN Healthcare Services (NYSE:AMN) for FY2026. Zacks Research increased their FY2026 EPS estimate to $0.69 from $0.67, while the consensus remains around $1.33. Analyst ratings are mixed with a consensus target price of $22.36, and the company recently beat Q4 earnings and revenue expectations but saw a 7.7% year-over-year revenue decline and a negative net margin.
Zacks Research Issues Positive Forecast for AMN Earnings
Zacks Research has increased its Q3 2026 EPS estimate for AMN Healthcare Services (NYSE:AMN) to $0.20 from $0.18, while maintaining a "Hold" rating on the stock. This update follows AMN's strong Q3 2025 earnings report, where the company significantly beat EPS and revenue expectations. Despite mixed analyst sentiment and the company's revenue being down 7.7% year-over-year, several firms have raised price targets, and the stock saw a dramatic intraday jump due to unusual options activity.
AMN Healthcare Services (NYSE:AMN) adds US$146m to market cap in the past 7 days, though investors from three years ago are still down 80%
AMN Healthcare Services has seen its market cap increase by US$146 million in the past week, but long-term investors are still facing a significant 80% loss over three years. The company's share price decline mirrors a fall into a loss-making position, indicating underlying business challenges. While recent performance shows some improvement, the company's fundamentals need careful consideration before investors commit.
AMN Healthcare Services (NYSE:AMN) Sees Unusually-High Trading Volume on Analyst Upgrade
AMN Healthcare Services (NYSE:AMN) experienced unusually high trading volume after BMO Capital Markets raised its price target on the stock from $22 to $25, maintaining an "outperform" rating. The stock traded near $19.87 with 1,559,756 shares exchanging hands, a 17% increase from the previous session. Despite mixed analyst ratings, the company boasts a consensus "Hold" rating with an average target price of $22.36, and it recently surpassed quarterly EPS estimates though revenue declined year-over-year.
AMN Healthcare Services (NYSE:AMN) Given New $25.00 Price Target at BMO Capital Markets
BMO Capital Markets has increased its price target for AMN Healthcare Services (NYSE:AMN) from $22.00 to $25.00, maintaining an "outperform" rating and implying a potential upside of 26.28%. Despite beating quarterly EPS and revenue estimates, the company experienced a 7.7% year-over-year revenue decline and reports negative net margin and P/E. Other analysts have mixed ratings, resulting in an average "Hold" rating with an average target price of $21.92 for AMN.
AMN Healthcare Services (NYSE:AMN) adds US$133m to market cap in the past 7 days, though investors from three years ago are still down 79%
AMN Healthcare Services (NYSE:AMN) recently saw its market cap increase by US$133 million in the past week, with a 22% rise in its share price over the last month. However, long-term investors are still facing a significant loss, with the stock down 79% over the past three years and 12% over five years. The company's earnings per share dropped to a loss during the period of share price decline, making EPS an unreliable indicator of its underlying business health.
AMN Healthcare Services Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
AMN Healthcare Services (NYSE: AMN) has received ratings from 4 analysts in the past three months, with an average price target of $22.88, a 6.42% increase from the previous average. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions. The company's financials show a negative revenue trend but strong net margin, return on equity, and return on assets, though its debt-to-equity ratio is higher than industry norms.
AMN Healthcare Services (NYSE:AMN) adds US$133m to market cap in the past 7 days, though investors from three years ago are still down 79%
AMN Healthcare Services (NYSE:AMN) saw a 22% share price increase in the last month, adding US$133 million to its market cap, but shareholders from three years ago are still down 79%. The company's earnings per share fell to a loss over that same three-year period, contributing to the significant share price decline, despite recent short-term gains. Longer-term investors are facing a 12% loss over five years, highlighting past underperformance.
3 Reasons to Sell AMN and 1 Stock to Buy Instead
AMN Healthcare Services has underperformed the S&P 500 since July 2025, with analysts pointing to declining demand shown by sliding sales volumes, a downward trend in EPS, and falling return on invested capital (ROIC). The article suggests that due to these factors and its current valuation, AMN does not pass a quality test, and investors should consider other growth stocks as better opportunities.
AMN Healthcare Services (NYSE:AMN) adds US$133m to market cap in the past 7 days, though investors from three years ago are still down 79%
AMN Healthcare Services (NYSE:AMN) has seen a 22% share price increase in the last month, adding US$133 million to its market cap. However, shareholders who invested three years ago are still down 79%, as the company's EPS dropped to a loss during that period. The article explores the disparity between recent gains and long-term losses, suggesting investors consider underlying business factors beyond mere sentiment.
AMN Healthcare Stock Pre-Market (+3.7%): J.P. Morgan Conference Outlook Drives Gains
AMN Healthcare (NYSE: AMN) saw its stock rise by 3.7% in pre-market trading, driven by the positive outlook surrounding the J.P. Morgan Conference. This gain suggests investor optimism following discussions or presentations at the financial event. The article itself is brief, primarily focusing on this immediate stock movement.
Why Is AMN Healthcare Services (AMN) Stock Soaring Today
AMN Healthcare Services (AMN) stock soared 17.2% after the company presented a positive outlook and strategic growth plans at the J.P. Morgan Healthcare Conference. The company emphasized its leadership in healthcare staffing, plans for growth through technology and acquisitions, and vision for sustainable revenue and profit margin growth. Investors reacted positively, despite the stock still trading significantly below its 52-week high.
Traders Buy Large Volume of AMN Healthcare Services Call Options (NYSE:AMN)
Traders showed significant bullish sentiment towards AMN Healthcare Services (NYSE:AMN) by purchasing 3,154 call options, representing a 474% increase over typical daily volume. This surge in options activity followed a substantial 17.6% jump in the stock's price after the company reported quarterly earnings that beat EPS estimates, despite a year-over-year revenue decline and a negative net margin. Institutional investors hold a large portion of the stock, while analyst ratings are mixed, with a consensus "Hold" rating.
Why Is AMN Healthcare Services (AMN) Stock Soaring Today
AMN Healthcare Services (AMN) stock surged 17.2% after the company presented a positive outlook and strategic growth plans at the J.P. Morgan Healthcare Conference. Management highlighted leadership in healthcare talent solutions, plans for technology integration and acquisitions, and long-term demand drivers, boosting investor confidence. Despite recent volatility and some declines in specific segments, AMN's year-to-date performance is positive, though it remains below its 52-week high.
